Aerosolization During Upper Endoscopy
Does Use of a Facemask Reduce the Risk of Aerosolization During Anesthesia Assisted Upper Endoscopic Procedures: A Randomized Controlled Trial
1 other identifier
interventional
57
1 country
1
Brief Summary
Given the current Covid-19 pandemic alongside the lack of evidence on aerosolization during upper endoscopy the investigators are conducting a randomized controlled trial seeking to assess both the level of aerosolization that occurs during these procedures along with determining if utilization of an endoscopic patient face-masks reduces the level of aerosolized particles. The protocol includes the use of a commercially available particle counter the investigators are employing for the measurement of aerosols before, during, and after anesthesia assisted upper endoscopic procedures. The investigators are recruiting patients undergoing these procedures with a target of 30 patients undergoing endoscopy without a facemask and 30 patients undergoing endoscopy with one.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2021
CompletedFirst Submitted
Initial submission to the registry
May 16, 2023
CompletedFirst Posted
Study publicly available on registry
August 23, 2023
CompletedResults Posted
Study results publicly available
November 13, 2025
CompletedNovember 13, 2025
October 1, 2025
2 months
May 16, 2023
May 29, 2024
October 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Aerosolization of Particles During Upper Endoscopy
Comparing the aerosolization of particles of six different sizes \[0.3μm, 0.5μm, 1μm, 2μm, 5μm and 10μm\] during endoscopy between patients using an endoscopic facemask to those without.
Start of endoscopy through the end of endoscopy
Study Arms (2)
Endoscopic Facemask
ACTIVE COMPARATORPatients undergoing endoscopy with the use of an endoscopic facemask
No Endoscopic Facemask
NO INTERVENTIONPatients undergoing endoscopy without an endoscopic facemask
Interventions
A commonly used endoscopic patient facemask that is normally used for oxygen delivery during endoscopy will be tested in this trial as a potential intervention for decreasing particle aerosolization
Eligibility Criteria
You may qualify if:
- All patients undergoing elective upper endoscopic procedures (upper endoscopy, ERCP, endoscopic ultrasound) with monitored anesthesia care at main campus Cleveland Clinic inpatient endoscopy unit.
You may not qualify if:
- Any patient requiring endotracheal intubation
- Pregnant patients
- Emergency procedures
- Patients who require use of a facemask before or during the procedure due to medical necessity
- Patients under the age of 18
- Non-English speaking individuals
- Patients unable to provide consent.
- Any procedure done outside the designated procedure room.
- If in the opinion of the anesthesiologist, a subject who was randomized to the control arm requires placement of the procedural mask to augment oxygenation, the subject will be removed from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anthony Lembolead
Study Sites (1)
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. John Vargo
- Organization
- Cleveland Clinic Foundation
Study Officials
- PRINCIPAL INVESTIGATOR
John Vargo, MD
Physician
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 16, 2023
First Posted
August 23, 2023
Study Start
August 31, 2021
Primary Completion
October 15, 2021
Study Completion
October 15, 2021
Last Updated
November 13, 2025
Results First Posted
November 13, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share